Market Place
Sourcing Support
FDA Posts Warning Letters To Manufacturers Of Breast Binders
19 Dec 2025 //
RAPS
Minnesota Jury Awards $65.5M vs. Johnson & Johnson
19 Dec 2025 //
BUSINESSWIRE
BMS’ Cobenfy TV Ad Is Latest Target Of FDA Untitled Letter Spree
19 Dec 2025 //
FIERCE PHARMA
AZ To Pull Bleeding Reversal Agent After FDA Flags Risk Imbalance
19 Dec 2025 //
FIERCE PHARMA
FDA hit Catalent`s Maryland Manufacturing Sites with Form 483
19 Dec 2025 //
FIERCE PHARMA
AKCDA Urges DCGI Action On Kerala Discount Pharmacies` Fake Drug
17 Dec 2025 //
PHARMABIZ
Novo Gets Warning Letter At Site Formerly Owned By Catalent
17 Dec 2025 //
FIERCE PHARMA
Trial By Fire: Over 60% Of Pharma SMEs May Be Forced To Shut Shop
16 Dec 2025 //
ECONOMICTIMES
US FDA sends warning letters to Walmart
15 Dec 2025 //
REUTERS
Himachal Drug Cos Under Stop Orders Found Operational
13 Dec 2025 //
ECONOMICTIMES
GAO Finds FDA Staffing Shortfalls Delaying Device Recall Work
12 Dec 2025 //
FIERCE BIOTECH
AICDF Seeks Pharma Prosecution for Decade-Long Non-Compliance
11 Dec 2025 //
PHARMABIZ
FDA Warns Companies For CGMP Violations, Unapproved Marketing
10 Dec 2025 //
RAPS
Merck, Sanofi, AZ Shots For RSV Now Under Scrutiny By FDA
09 Dec 2025 //
FIERCE PHARMA
India Pharma Inc Shifts From Compliance To Commitment In Safety
09 Dec 2025 //
EXPRESSPHARMA
FDA Panel Votes Against J&J Shunt Implant For Heart Failure
05 Dec 2025 //
FIERCE BIOTECH
USFDA Issues Form 483 With 3 Observations To Ipca`s Tarapur Plant
05 Dec 2025 //
ECONOMICTIMES
Precipio Identifies Unauthorized Access to Isolated Storage
04 Dec 2025 //
GLOBENEWSWIRE
FDA Official: CDER Warning Letters Up 50% In FY 2025
04 Dec 2025 //
RAPS
DOJ, FDA Prosecutions Highlight HCG Sales Risks
04 Dec 2025 //
PR NEWSWIRE
Bihar IPA Criticizes Regulatory Failure As DEG Syrup Kills 23
04 Dec 2025 //
PHARMABIZ
FDA Letter To Daiichi Takes Aim At Turalio Patient Video
04 Dec 2025 //
FIERCE PHARMA
Indonesia Firm Executive Suspect in Radioactive Contamination
04 Dec 2025 //
REUTERS
Ethiopian Team Visits Telangana for Drug Regulation Study
28 Nov 2025 //
PHARMABIZ
Torrent Pharma Fined Rs 41 Crore Over Alleged Wrong GST Refund
28 Nov 2025 //
ECONOMICTIMES
FDA Grants VAI Status to Biocon`s Bengaluru Facility
27 Nov 2025 //
ECONOMICTIMES
CDSCO Bans High-Risk Solvents in Pediatric Oral Drugs
27 Nov 2025 //
BUSINESS STD
Glenmark Pharma Gets VAI From FDA For Monroe Facility
27 Nov 2025 //
INDPHARMAPOST
CDSCO Panel Calls For Consistent Drug Standard Enforcement
27 Nov 2025 //
BUSINESS STD
Telangana DCA Enforces CDSCO Mandate For Drug Safety Reporting
26 Nov 2025 //
PHARMABIZ
Sanofi Caught Up In Tax Fraud Probe Involving Several Companies
26 Nov 2025 //
FIERCE PHARMA
Haryana FDA Hosts Summit on Spurious Drugs, NDPS Fight
25 Nov 2025 //
PHARMABIZ
Abbott Urgently Corrects Freestyle Libre 3 Sensors Over Safety
25 Nov 2025 //
INDPHARMAPOST
Commenters Advocate For Clearer Safety Label Guidance
24 Nov 2025 //
RAPS
Lupin Gets 7 Observations From USFDA For Goa Facility
24 Nov 2025 //
INDPHARMAPOST
CDSCO Reports Highest Number Of NSQs In 2025 In October
24 Nov 2025 //
PHARMABIZ
Shilpa Medicare Gets 8 Observations From FDA For Jadcherla Unit 4
24 Nov 2025 //
INDPHARMAPOST
Abbott To Replace CGMs After Incorrect Readings, Death Reports
24 Nov 2025 //
FIERCE BIOTECH
Solara`s Mangalore Facility Clears FDA Inspection With VAI Status
23 Nov 2025 //
INDPHARMAPOST
CDSCO Identifies 211 Drug Samples As NSQs, 5 As Spurious
22 Nov 2025 //
PHARMABIZ
NATCO API unit gets 7 observations from FDA Read more
22 Nov 2025 //
ET PHARMA
AIOCD Asks Traders To Strictly Comply With The Ban On 35 Fdcs
21 Nov 2025 //
PHARMABIZ
NABL Sets Terms For Labs To Obtain And Keep Accreditation
21 Nov 2025 //
PHARMABIZ
Piramal Pharma Solutions` UK Site Secures Renewed MHRA GMP
21 Nov 2025 //
INDPHARMAPOST
Texas Sues Sanofi, BMS Over `Deceptive` Plavix Marketing
21 Nov 2025 //
FIERCE PHARMA
Takeda`s Adzynma draws FDA scrutiny after paediatric death
21 Nov 2025 //
FDA
Pfizer, Tris Settle ADHD Drug Claims With $41.5M In Texas
20 Nov 2025 //
FIERCE PHARMA
Regulator Tightens Rules on High-Risk Solvents Post Syrup Deaths
19 Nov 2025 //
ECONOMICTIMES
KSMSCL Strengthens Drug Procurement With Quarantine Measures
18 Nov 2025 //
PHARMABIZ
OTC Morning-After Pills Sold in Varying Doses with Warnings
18 Nov 2025 //
ECONOMICTIMES
Astrazeneca Lands OPDP Untitled Letter Over Farxiga TV Ad
17 Nov 2025 //
RAPS
AIOCD & RDCA Support Regulatory Crackdown On MTP & Narcotic Drug
17 Nov 2025 //
PHARMABIZ
Medico Remedies Receives GMP Certificate From SMDC, In Ukraine
16 Nov 2025 //
INDPHARMAPOST
Aurobindo Pharma Receives 9 Observations From USFDA For Eugia
15 Nov 2025 //
INDPHARMAPOST
Regulator Tightens Quality Checks, Threatening Small Pharma Firms
13 Nov 2025 //
ECONOMICTIMES
Omnicell Secures URAC Certification For Health System Pharmacies
13 Nov 2025 //
BUSINESSWIRE
FDA Warns Companies For GMP And Unapproved Drug Violations
13 Nov 2025 //
RAPS
HEMP Crackdown, Court Rulings Reinforce MMJ’s Pharma Vision
12 Nov 2025 //
PHARMIWEB
Fresenius, Sun, Teva & Others Launched Drug Recalls This Fall
12 Nov 2025 //
FIERCE PHARMA
Byheart Broadens Voluntary Recall While Investigation Continues
11 Nov 2025 //
BUSINESSWIRE
